Analyst Julian Harrison works at BTIG and is covering the the Healthcare sector with 33 price targets and ratings documented since 2020 spanning on 8 stocks.
Julian Harrison's average stock forecast success ratio is 37.5% with an average time for price targets to be met of 97.5 days.
Most recent stock forecast was given on ACRS, Aclaris Therapeutics, Inc at 07-Mar-2023.
Analyst best performing recommendations are on AVTE.
The best stock recommendation documented was for AVTE at 12/6/2022. The price target of $27 was fulfilled within 6 days with a profit of $8.97 (49.75%) receiving and performance score of 82.92.
Average potential price target upside
Currently, out of the existing stock ratings of Julian Harrison - 3 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
40
$11.01 (37.98%)
60
14 days ago
1/3 (33.33%)
$16.44 (62.17%)
216
Buy
28
$-0.99 (-3.41%)
31
2 months 23 days ago
3/6 (50%)
$16.25 (62.94%)
110
Buy
38
$9.01 (31.08%)
50
2 months 23 days ago
4/8 (50%)
$15.56 (78.85%)
277
Buy
35
$6.01 (20.73%)
93
4 months 22 days ago
0/8 (0%)
$42.71 (162.11%)
Buy
70
1 years 1 months 25 days ago
1/8 (12.5%)
$24.63 (98.50%)
57
